|
CH528514A
(de)
|
1969-05-22 |
1972-09-30 |
Bayer Ag |
Verfahren zur Herstellung von Acylimidazolen
|
|
US4721712A
(en)
|
1984-06-12 |
1988-01-26 |
Pfizer Inc. |
1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
|
|
CN1030415A
(zh)
|
1987-02-20 |
1989-01-18 |
山之内制药株式会社 |
饱和的杂环碳酰胺衍生物和它的制备方法
|
|
DE69132006T2
(de)
*
|
1990-11-30 |
2000-08-03 |
Otsuka Pharmaceutical Co., Ltd. |
Thiazolederivate als inhibitoren von aktivem sauerstoff
|
|
US5120749A
(en)
*
|
1991-02-20 |
1992-06-09 |
Abbott Laboratories |
Platelet activating antagonists
|
|
GB2287196B
(en)
|
1991-09-30 |
1995-11-15 |
Philip Richardson |
A surgical incision member for use in suturing
|
|
NO924963L
(no)
*
|
1991-12-27 |
1993-06-28 |
Sankyo Co |
Pyridyltiazolidinkarboksylsyreamid-derivater og fremgangsmaate til fremstilling derav
|
|
JP3393891B2
(ja)
|
1992-08-18 |
2003-04-07 |
塩野義製薬株式会社 |
イミダゾール類の製造方法
|
|
US5514690A
(en)
|
1992-11-17 |
1996-05-07 |
E. R. Squibb & Sons, Inc. |
Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
|
|
JP2550915B2
(ja)
|
1994-06-21 |
1996-11-06 |
日本電気株式会社 |
印刷配線板の表面保護剤および表面保護膜の形成方法
|
|
DK0798298T3
(da)
|
1994-12-15 |
2001-10-22 |
Sankyo Co |
Thiazolidinon- eller oxazolidonderivater til behandling af angina pectoris eller sammensætninger indeholdende samme som aktiv bestanddel
|
|
WO1996026931A1
(en)
|
1995-03-02 |
1996-09-06 |
Sankyo Company, Limited |
Optically active thiazolidinone derivatives
|
|
EP0996443A1
(en)
|
1997-07-03 |
2000-05-03 |
Neurogen Corporation |
Certain diarylimidazole derivatives; a new class of npy specific ligands
|
|
JP2004067510A
(ja)
|
1997-12-26 |
2004-03-04 |
Mitsubishi Pharma Corp |
新規イミダゾール誘導体
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
AU7354900A
(en)
*
|
1999-09-09 |
2001-04-10 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
JP2001240593A
(ja)
*
|
1999-10-12 |
2001-09-04 |
Japan Tobacco Inc |
高トリグリセリド血症治療薬及び抗肥満薬
|
|
CA2395716A1
(en)
|
1999-12-27 |
2001-07-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
|
|
DE60129222T2
(de)
*
|
2000-05-11 |
2008-03-06 |
Consejo Superior de Investigaciónes Científicas |
Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
|
|
ES2257461T3
(es)
|
2000-12-21 |
2006-08-01 |
Bristol-Myers Squibb Company |
Inhibidores de tiazolilo de tirosina quinasas de la familia tec.
|
|
EP1381602A1
(en)
*
|
2001-04-19 |
2004-01-21 |
Vertex Pharmaceuticals Incorporated |
Heterocyclyldicarbamides as caspase inhibitors
|
|
WO2003016338A1
(en)
|
2001-08-15 |
2003-02-27 |
Parker Hughes Institute |
Crystal structure of the btk kinase domain
|
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
UY27450A1
(es)
*
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
|
WO2003027101A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
|
|
US20040267017A1
(en)
|
2001-09-26 |
2004-12-30 |
Bierer Donald E |
3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
|
|
ES2256560T3
(es)
|
2001-10-12 |
2006-07-16 |
Bayer Pharmaceuticals Corporation |
Heterociclos de 5 mienbros que contienen nitrogeno sustituidos con felino para el tratamiento de la obesidad.
|
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
|
JP2005513026A
(ja)
|
2001-11-15 |
2005-05-12 |
インサイト サン ディエゴ インコーポレイテッド |
高コレステロール血症、異脂肪血症および他の代謝障害；癌、および他の疾患を治療するｎ−置換複素環
|
|
CA2481995A1
(en)
|
2002-04-08 |
2003-10-16 |
Torrent Pharmaceuticals Ltd. |
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
|
|
WO2003090680A2
(en)
|
2002-04-23 |
2003-11-06 |
Axys Pharmaceuticals, Inc. |
Novel phenyl derivatives as inducers of apoptosis
|
|
TW200404796A
(en)
*
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
|
AU2003293376A1
(en)
|
2002-12-10 |
2004-06-30 |
Imclone Systems Incorporated |
Anti-angiogenic compounds and their use in cancer treatment
|
|
CA2515215A1
(en)
|
2003-02-10 |
2004-08-26 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
CN1747936A
(zh)
|
2003-02-12 |
2006-03-15 |
特兰斯泰克制药公司 |
作为治疗试剂的取代吡咯衍生物
|
|
PL378919A1
(pl)
|
2003-04-10 |
2006-06-12 |
Avanir Pharmaceuticals |
Pochodne imidazolu do leczenia zaburzeń alergicznych i nadmiernego rozrostu
|
|
US7132440B2
(en)
|
2003-04-17 |
2006-11-07 |
Janssen Pharmaceutica, N.V. |
Substituted benzimidazoles and imidazo-[4,5]-pyridines
|
|
EP1626713A2
(en)
|
2003-05-16 |
2006-02-22 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
|
US6787245B1
(en)
|
2003-06-11 |
2004-09-07 |
E. I. Du Pont De Nemours And Company |
Sulfonated aliphatic-aromatic copolyesters and shaped articles produced therefrom
|
|
PT1658263E
(pt)
*
|
2003-07-24 |
2010-09-06 |
Leo Pharma As |
Novos compostos de aminobenzofenona
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
AU2004291539A1
(en)
|
2003-11-18 |
2005-06-02 |
Ohio State University Research Foundation |
Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
|
|
US20060014740A1
(en)
|
2003-11-18 |
2006-01-19 |
Miller Duane D |
Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
|
|
EP2284157A1
(en)
*
|
2003-12-12 |
2011-02-16 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
US7326732B2
(en)
*
|
2004-02-12 |
2008-02-05 |
Pharmagene Laboratories Limited |
EP2 receptor agonists
|
|
BRPI0508594A
(pt)
*
|
2004-03-08 |
2007-08-21 |
Wyeth Corp |
moduladores de canal de ìon
|
|
CA2565965A1
(en)
*
|
2004-05-06 |
2006-07-27 |
Plexxikon, Inc. |
Pde4b inhibitors and uses therefor
|
|
EP2298291A3
(en)
|
2004-06-18 |
2011-08-03 |
Agennix USA Inc. |
Kinase inhibitors for treating cancers
|
|
KR20090006885A
(ko)
|
2004-08-17 |
2009-01-15 |
에프. 호프만-라 로슈 아게 |
치환 히단토인
|
|
US20060211603A1
(en)
*
|
2004-08-18 |
2006-09-21 |
Vicuron Pharmaceuticals Inc. |
Ramoplanin derivatives possessing antibacterial activity
|
|
EP1627876A1
(en)
|
2004-08-20 |
2006-02-22 |
Ferring B.V. |
Heterocyclic condensed compounds useful as antidiuretic agents
|
|
EP1637529A1
(en)
*
|
2004-09-20 |
2006-03-22 |
4Sc Ag |
Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
|
|
AU2005316034B2
(en)
*
|
2004-12-13 |
2012-01-19 |
Leo Pharma A/S |
Triazole substituted aminobenzophenone compounds
|
|
CN101137412B
(zh)
|
2005-01-13 |
2012-11-07 |
布里斯托尔-迈尔斯·斯奎布公司 |
用作凝血因子XIa抑制剂的取代的二芳基化合物
|
|
WO2006076706A1
(en)
*
|
2005-01-14 |
2006-07-20 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
|
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
NZ564065A
(en)
*
|
2005-05-20 |
2011-03-31 |
Vertex Pharma |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
WO2008036067A2
(en)
|
2005-07-19 |
2008-03-27 |
The University Of Tennessee Research Foundation |
Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
|
|
KR20080031038A
(ko)
|
2005-07-29 |
2008-04-07 |
4에스체 악티엔게젤샤프트 |
신규의 헤테로환 ＮＦ-κＢ 억제제
|
|
EP1937649A1
(en)
*
|
2005-10-14 |
2008-07-02 |
Neurosearch A/S |
Imidazole derivatives for the treatment of anxiety and related diseases
|
|
US8637559B2
(en)
*
|
2005-11-15 |
2014-01-28 |
Otsuka Pharmaceutical Co., Ltd. |
Oxazole compound and pharmaceutical composition
|
|
KR101081293B1
(ko)
|
2006-01-18 |
2011-11-08 |
에프. 호프만-라 로슈 아게 |
11 베타-에이치에스디1 억제제로서 티아졸
|
|
US7612212B2
(en)
|
2006-02-22 |
2009-11-03 |
Hoffmann-La Roche Inc. |
Substituted hydantoins
|
|
EP1832585A1
(en)
*
|
2006-03-10 |
2007-09-12 |
ORIDIS BIOMED Forschungs- und Entwicklungs GmbH |
Thiazole-piperidine derivatives for treatment of hyperproliferative diseases
|
|
EP1834954A1
(en)
*
|
2006-03-15 |
2007-09-19 |
4Sc Ag |
Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
|
|
WO2007115805A2
(en)
*
|
2006-04-05 |
2007-10-18 |
European Molecular Biology Laboratory (Embl) |
Aurora kinase inhibitors
|
|
WO2007146230A2
(en)
|
2006-06-14 |
2007-12-21 |
Merck & Co., Inc. |
Non-nucleoside reverse transcriptase inhibitors
|
|
BRPI0712642A2
(pt)
*
|
2006-07-13 |
2012-05-29 |
Bayer Cropscience Sa |
"composto, composição fungicida, uso de um composto e método de controle curativo ou preventivo dos fungos fitopatogênicos"
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
EP2049520A4
(en)
*
|
2006-08-07 |
2011-01-05 |
Ironwood Pharmaceuticals Inc |
indole compounds
|
|
BRPI0714908B8
(pt)
*
|
2006-08-08 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
derivados de pirimidina como inibidor de pi3k, composição farmacêutica e agente preventivo ou agente terapêutico de uma doença proliferativa que os compreende
|
|
JPWO2008023720A1
(ja)
*
|
2006-08-23 |
2010-01-14 |
アステラス製薬株式会社 |
ウレア化合物又はその塩
|
|
EP2061761A1
(en)
*
|
2006-09-07 |
2009-05-27 |
Millennium Pharmaceuticals, Inc. |
Phenethylamide derivatives with kinase inhibitory activity
|
|
KR100932093B1
(ko)
|
2006-09-27 |
2009-12-16 |
주식회사종근당 |
미세소관 형성 저해제로서 유용한 벤조페논 유도체
|
|
US7795249B2
(en)
*
|
2006-12-22 |
2010-09-14 |
Millennium Pharmaceuticals, Inc. |
Certain pyrazoline derivatives with kinase inhibitory activity
|
|
US20080255213A1
(en)
|
2007-04-14 |
2008-10-16 |
University Of Tennessee Research Foundation |
Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
|
|
US20090142832A1
(en)
|
2007-11-29 |
2009-06-04 |
James Dalton |
Indoles, Derivatives, and Analogs Thereof and Uses Therefor
|
|
US8389567B2
(en)
|
2007-12-12 |
2013-03-05 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US9029408B2
(en)
*
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
UA105005C2
(uk)
|
2008-06-16 |
2014-04-10 |
Юніверсіті Оф Теннессі Рісерч Фаундейшн |
Сполуки для лікування раку
|
|
DK3560498T3
(da)
|
2009-10-16 |
2022-11-14 |
Novartis Ag |
Kombination, der omfatter en mek-hæmmer og en b-raf-hæmmer
|
|
KR101134194B1
(ko)
|
2009-12-03 |
2012-04-09 |
서울대학교산학협력단 |
헤테로바이아릴피리딘 유도체 화합물의 제조방법 및 이러한 방법에 의해 제조된 헤테로바이아릴피리딘 유도체 화합물
|
|
EP3064204A1
(en)
|
2010-03-01 |
2016-09-07 |
GTx, Inc. |
Compounds for treatment of cancer
|
|
WO2012027716A1
(en)
|
2010-08-27 |
2012-03-01 |
Collabrx, Inc. |
Method to treat melanoma in braf inhibitor-resistant subjects
|
|
US9348332B2
(en)
|
2011-03-29 |
2016-05-24 |
Mitsubishi Electric Corporation |
Abnormality diagnosis device and abnormality diagnosis system for servo control device
|
|
CN103841975A
(zh)
|
2011-04-01 |
2014-06-04 |
基因泰克公司 |
Akt抑制剂化合物和厄洛替尼的组合以及使用方法
|
|
DK2694510T3
(en)
|
2011-04-07 |
2016-01-18 |
Bayer Ip Gmbh |
IMIDAZOPYRIDAZINER AS AKT kinase inhibitors
|
|
EP2964028A4
(en)
*
|
2013-03-05 |
2017-06-07 |
University of Tennessee Research Foundation |
Compounds for treatment of cancer
|